DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vandetanib (Vandetanib) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vandetanib disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vandetanib side effects in female

Reported by a pharmacist from France on 2012-06-28

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Visual Acuity Reduced, Corneal Deposits

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vandetanib
    Administration route: Oral
    Start date: 2007-11-01
    End date: 2010-11-01

Vandetanib
    Administration route: Oral
    Indication: Thyroid Cancer
    Start date: 2007-02-28
    End date: 2007-11-01

Vandetanib
    Administration route: Oral
    Start date: 2010-12-14
    End date: 2011-06-20

Vandetanib
    Administration route: Oral
    End date: 2012-05-16

Other drugs received by patient: Pravastatin; Levothyroxine Sodium; Potassium Chloride; UN-Alpha; Nicardipine Hydrochloride



Possible Vandetanib side effects in female

Reported by a pharmacist from France on 2012-06-14

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Visual Acuity Reduced, Corneal Deposits

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vandetanib
    Administration route: Oral
    Indication: Thyroid Cancer
    Start date: 2007-02-28
    End date: 2007-11-01

Vandetanib
    Administration route: Oral
    Start date: 2007-11-01
    End date: 2010-11-01

Vandetanib
    Administration route: Oral
    Start date: 2010-12-14
    End date: 2011-06-20

Vandetanib
    Administration route: Oral
    End date: 2012-05-16

Other drugs received by patient: Nicardipine Hydrochloride; Levothyroxine Sodium; Pravastatin; UN-Alpha; Potassium Chloride

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017